How does the “written description” requirement relate to the enablement requirement?
The written description requirement is distinct from, but related to, the enablement requirement in patent law. As stated in MPEP 2304.02(d): “The written description requirement is separate and distinct from the enablement requirement. Ariad Pharm., Inc. v. Eli Lilly & Co., 598 F.3d 1336, 1340, 94 USPQ2d 1161, 1167 (Fed. Cir. 2010) (en banc).” While…
Read More